Skip to main content

Colorectal Cancer Topic Center

Industry Insights
Expert Perspectives

podcasts


Headshot of Pashtoon Kasi, MD, MS, Weill Cornell Medicine, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
09/23/2022
Maria Asimopoulos
Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, describes several recent advancements in specific subsets of colorectal cancer and emphasizes the role of biomarker testing for...
Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, describes several recent advancements in specific subsets of colorectal cancer and emphasizes the role of biomarker testing for...
Pashtoon Kasi, MD, MS,...
09/23/2022
First Report Managed Care
Headshot of Pashtoon Kasi, MD, MS, Weill Cornell Medicine, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
08/15/2022
Maria Asimopoulos
Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, discusses why biomarker testing rates are low among patients with metastatic colorectal cancer, as well as what changes can be...
Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, discusses why biomarker testing rates are low among patients with metastatic colorectal cancer, as well as what changes can be...
Pashtoon Kasi, MD, MS,...
08/15/2022
First Report Managed Care